Lupin’s arm achieves NABL accreditation across all greenfield labs

23 Apr 2025 Evaluate

Lupin’s wholly owned subsidiary -- Lupin Diagnostics (LDL) has achieved 100% National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation across all its greenfield labs.  This notable achievement highlights the adherence to rigorous quality control measures, reinforcing LDL’s unwavering dedication to providing top-tier diagnostic services. The company’s commitment to quality is reflected in every aspect of its operations, ensuring patients receive accurate and timely results that they can trust. 

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×